Cargando…
LUPUS-BEST—treat-to-target in systemic lupus erythematosus: study protocol for a three-armed cluster-randomised trial
INTRODUCTION: As chronic systemic autoimmune disease, which can affect every organ, SLE is creating significant burden and increased mortality. Despite better outcomes over the past decades by optimising standard of care, new interventions are needed for further improvements. Changing strategy to ‘t...
Autores principales: | Mucke, Johanna, Kuss, Oliver, Brinks, Ralph, Schanze, Sabine, Schneider, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268883/ https://www.ncbi.nlm.nih.gov/pubmed/34253649 http://dx.doi.org/10.1136/lupus-2021-000516 |
Ejemplares similares
-
Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections
por: Mucke, Johanna, et al.
Publicado: (2019) -
Incidence of systemic lupus erythematosus in Colombia: data from the
National Health Registry 2012–2016
por: Haase, I, et al.
Publicado: (2019) -
Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification
por: Marasco, Emiliano, et al.
Publicado: (2022) -
Delayed diagnosis adversely affects outcome in systemic lupus
erythematosus: Cross sectional analysis of the LuLa cohort
por: Kernder, Anna, et al.
Publicado: (2021) -
Methyl donor micronutrients, CD40-ligand methylation and disease
activity in systemic lupus erythematosus: A cross-sectional association
study
por: Vordenbäumen, Stefan, et al.
Publicado: (2021)